| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.09 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |